Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (5) , 865-870
- https://doi.org/10.1016/s0015-0282(01)01689-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- The pharmacodynamics and efficacy of Implanon®Contraception, 1998
- Classification and comparison of oral contraceptives containing new generation progestogensHuman Reproduction Update, 1995
- Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrelContraception, 1995
- Clinical experience and pharmacological effects of an oral contraceptive containing 20μg oestrogenContraception, 1992